Argenica Therapeutics

Nedlands, Australia

Argenica Therapeutics is a developing novel neuroprotective therapeutics to reduce brain damage after stroke

$647K raised

Jun 2025

Grant

Biotechnology

Top Investors

MTPConnect

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Argenica Therapeutics

How much funding has Argenica Therapeutics raised?

Argenica Therapeutics has raised $647K in total funding. The most recent round was Grant. The last funding was announced in June 2025.

Who are Argenica Therapeutics's investors?

Argenica Therapeutics's investors include MTPConnect.

Where is Argenica Therapeutics headquartered?

Argenica Therapeutics is headquartered in Nedlands, Australia.

What does Argenica Therapeutics do?

Argenica Therapeutics is a developing novel neuroprotective therapeutics to reduce brain damage after stroke

What stage is Argenica Therapeutics at?

Argenica Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 20, 2025.

MLA

"Argenica Therapeutics — Funding & Investors." VCBacked, June 20, 2025, https://www.vcbacked.co/company/argenica-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2025). Argenica Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/argenica-therapeutics

Wikipedia (cite web)

{{cite web |title=Argenica Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/argenica-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 20, 2025.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K